New York State Common Retirement Fund Blueprint Medicines Corp Transaction History

New York State Common Retirement Fund

  • $73.9 Billion
  • Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Blueprint Medicines Corp stock. As of the latest transaction made, New York State Common Retirement Fund holds 19,520 shares of BPMC stock, worth $1.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,520
Previous 32,695 40.3%
Holding current value
$1.73 Million
Previous $3.52 Million 48.75%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$84.1 - $120.5 $1.11 Million - $1.59 Million
-13,175 Reduced 40.3%
19,520 $1.81 Million
Q2 2024

Jul 31, 2024
SELL
$85.18 - $108.78 $347,704 - $444,039
-4,082 Reduced 11.1%
32,695 $3.52 Million
Q1 2024

May 07, 2024
BUY
$73.17 - $99.79 $172,022 - $234,606
2,351 Added 6.83%
36,777 $3.49 Million
Q4 2023

Feb 01, 2024
SELL
$43.96 - $92.84 $116,406 - $245,840
-2,648 Reduced 7.14%
34,426 $3.18 Million
Q3 2023

Nov 07, 2023
BUY
$46.9 - $66.0 $97,458 - $137,148
2,078 Added 5.94%
37,074 $1.86 Million
Q2 2023

Aug 07, 2023
SELL
$42.2 - $66.37 $292,403 - $459,877
-6,929 Reduced 16.53%
34,996 $2.21 Million
Q1 2023

May 02, 2023
SELL
$37.97 - $50.0 $404,380 - $532,500
-10,650 Reduced 20.26%
41,925 $1.89 Million
Q4 2022

Jan 30, 2023
BUY
$41.06 - $66.48 $114,803 - $185,878
2,796 Added 5.62%
52,575 $2.3 Million
Q3 2022

Nov 08, 2022
BUY
$49.93 - $77.7 $255,691 - $397,901
5,121 Added 11.47%
49,779 $3.28 Million
Q2 2022

Aug 04, 2022
SELL
$45.23 - $70.15 $263,238 - $408,273
-5,820 Reduced 11.53%
44,658 $2.26 Million
Q1 2022

May 05, 2022
BUY
$54.1 - $110.08 $110,472 - $224,783
2,042 Added 4.22%
50,478 $3.23 Million
Q4 2021

Feb 02, 2022
SELL
$94.25 - $115.99 $21,300 - $26,213
-226 Reduced 0.46%
48,436 $5.19 Million
Q3 2021

Nov 02, 2021
SELL
$80.98 - $109.47 $749,955 - $1.01 Million
-9,261 Reduced 15.99%
48,662 $5 Million
Q2 2021

Aug 02, 2021
SELL
$82.78 - $101.0 $2,235 - $2,727
-27 Reduced 0.05%
57,923 $5.1 Million
Q4 2020

Feb 08, 2021
SELL
$92.08 - $124.48 $23,020 - $31,120
-250 Reduced 0.43%
57,950 $6.5 Million
Q3 2020

Nov 05, 2020
BUY
$66.45 - $92.7 $59,805 - $83,430
900 Added 1.57%
58,200 $5.4 Million
Q2 2020

Aug 07, 2020
BUY
$57.09 - $79.27 $496,683 - $689,649
8,700 Added 17.9%
57,300 $4.47 Million
Q1 2020

May 06, 2020
BUY
$48.11 - $82.22 $226,117 - $386,434
4,700 Added 10.71%
48,600 $2.84 Million
Q4 2019

Feb 05, 2020
SELL
$66.73 - $82.59 $473,783 - $586,389
-7,100 Reduced 13.92%
43,900 $3.52 Million
Q3 2019

Nov 07, 2019
SELL
$72.9 - $101.41 $241,444 - $335,869
-3,312 Reduced 6.1%
51,000 $3.75 Million
Q2 2019

Aug 09, 2019
BUY
$73.54 - $97.8 $237,901 - $316,383
3,235 Added 6.33%
54,312 $5.12 Million
Q1 2019

May 08, 2019
BUY
$48.7 - $86.6 $510,229 - $907,308
10,477 Added 25.81%
51,077 $4.09 Million
Q4 2018

Feb 08, 2019
SELL
$45.57 - $74.26 $432,277 - $704,430
-9,486 Reduced 18.94%
40,600 $2.19 Million
Q2 2018

Aug 10, 2018
SELL
$60.96 - $101.18 $339,120 - $562,864
-5,563 Reduced 10.0%
50,086 $3.18 Million
Q1 2018

May 10, 2018
BUY
$73.28 - $102.95 $338,187 - $475,114
4,615 Added 9.04%
55,649 $5.1 Million
Q4 2017

Feb 13, 2018
BUY
$62.91 - $88.32 $158,973 - $223,184
2,527 Added 5.21%
51,034 $3.85 Million
Q3 2017

Nov 06, 2017
BUY
$42.37 - $69.67 $162,488 - $267,184
3,835 Added 8.58%
48,507 $3.38 Million
Q2 2017

Aug 11, 2017
BUY
N/A
44,672
44,672 $2.26 Million

Others Institutions Holding BPMC

# of Institutions
350
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.3B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email